Predicting fluoroquinolones ability to kill resistant streptococcus pneumoniae isolates expressing different genetic mutations: target attainment analysis simulating therapeutic doses to patients with community acquired pneumonia
eradicating infections and preventing continued growth of resistance. Methods: Using patient data from strep pneumonia patients in hospitals and MIC data from the CROSS study, drug regimens were compared

